Nonhuman primate model of pertussis

Infection and Immunity

Volumn 80, Issue 4, 2012, Pages 1530-1536

  Warfel, Jason M ^a   Beren, Joel ^a   Kelly, Vanessa K ^a   Lee, Gloria ^a   Merkel, Tod J ^a  

^a CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BABOON; BACTERIAL COLONIZATION; BACTERIAL STRAIN; BORDETELLA PERTUSSIS; CONTROLLED STUDY; COUGHING; IMMUNE RESPONSE; NONHUMAN; PERTUSSIS; PRIORITY JOURNAL; RECOVERY ROOM; RHESUS MONKEY; ANIMAL; BLOOD; DISEASE MODEL; GROWTH, DEVELOPMENT AND AGING; IMMUNOLOGY; MACACA MULATTA;

BACTERIUM ANTIBODY; PERTUSSIS VACCINE;

ANIMALS; ANTIBODIES, BACTERIAL; BORDETELLA PERTUSSIS; DISEASE MODELS, ANIMAL; MACACA MULATTA; PAPIO; PERTUSSIS VACCINE; WHOOPING COUGH;

EID: 84860796845     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.06310-11     Document Type: Article

References (31)

1. CDC. 2011. Pertussis, p 215-232. In Epidemiology and prevention of vaccine-preventable diseases, 12th ed. Centers for Disease Control and Prevention, Atlanta, GA.
2. CDC. 2011. Provisional cases of selected notifiable diseases. MMWR Morb. Mortal. Wkly. Rep. 59:1706 -1716.
3. Cherry JD, Gornbein J, Heininger U, Stehr K. 1998. A search for serologic correlates of immunity to Bordetella pertussis cough illnesses. Vaccine 16:1901-1906.
4. Cherry JD, Heininger U. 2009. Pertussis and other bordetella infections, p 1683-1706. In Feigin RD, Cherry JD, Demmler-Harrison GJ, Kaplan SL (ed), Textbook of pediatric infectious diseases. W. B. Saunders, Philadelphia, PA.
5. Culotta CS, Harvey DF, Gordon EF. 1935. Whooping cough. II. Experimental study. J. Pediatr. 6:743-752.
6. Dalby T, Petersen JW, Harboe ZB, Krogfelt KA. 2010. Antibody responses to pertussis toxin display different kinetics after clinical Bordetella pertussis infection than after vaccination with an acellular pertussis vaccine. J. Med. Microbiol. 59:1029 -1036.
7. Dalby T, Seier-Petersen M, Kristiansen MP, Harboe ZB, Krogfelt KA. 2009. Problem solved: a modified enzyme-linked immunosorbent assay for detection of human antibodies to pertussis toxin eliminates falsepositive results occurring at analysis of heat-treated sera. Diagn. Microbiol. Infect. Dis. 63:354 -360.
8. Elahi S, Holmstrom J, Gerdts V. 2007. The benefits of using diverse animal models for studying pertussis. Trends Microbiol. 15:462-468.
9. Friedrich MJ. 2011. Research aims to boost pertussis control. JAMA 306: 27-29.
10. Heininger U. 2010. Update on pertussis in children. Expert Rev. Anti Infect. Ther. 8:163-173.
11. Hewlett EL, Kim KJ, Lee SJ, Gray MC. 2000. Adenylate cyclase toxin from Bordetella pertussis: current concepts and problems in the study of toxin functions. Int. J. Med. Microbiol. 290:333-335.
12. Hozbor D, et al. 2009. Pertussis epidemiology in Argentina: trends over 2004-2007. J. Infect. 59:225-231.
13. Huang CC, et al. 1962. Experimental whooping cough. N. Engl. J. Med. 266:105-111.
14. Knapp S, Mekalanos JJ. 1988. Two trans-acting regulatory genes (vir and mod) control antigenic modulation in Bordetella pertussis. J. Bacteriol. 170:5059 -5066.
15. Reference deleted.
16. Lin TM. 1958. Experimental whooping cough in monkey. J. Formos. Med. Assoc. 57:53-62.
17. Mattoo S, Cherry JD . 2005. Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies. Clin. Microbiol. Rev. 18:326 -382.
18. Murayama T, Hewlett EL, Maloney NJ, Justice JM, Moss J. 1994. Effect of temperature and host factors on the activities of pertussis toxin and Bordetella adenylate cyclase. Biochemistry 33:15293-15297.
19. North EA, Keogh EV, Christie R, Anderson G. 1940. Experimental pertussis in the monkey. Aust. J. Exp. Biol. Med. Sci. 18:125-130.
20. Quinn HE, McIntyre PB. 2007. Pertussis epidemiology in Australia over the decade 1995-2005-trends by region and age group. Commun. Dis. Intell. 31:205-215.
21. Rich AR, Long PH, Brown JH, Bliss EA, Holt LE. 1932. Experiments upon the cause of whooping cough. Science 76:330 -331.
22. Sauer LW, Hambrecht L. 1928. Experimental whooping cough. Am. J. Dis. Child. 37:732-744.
23. Schneider DR, Parker CD. 1982. Effect of pyridines on phenotypic properties of Bordetella pertussis. Infect. Immun. 38:548 -553.
24. Shibley GS. 1934. Etiology of whooping cough. Proc. Soc. Exp. Biol. Med. 31:576 -579.
25. Stibitz ES. 2006. The bvgASR locus of Bordetella pertussis, p 47-67. In Locht C (ed), Bordetella molecular biology. Horizon Scientific Press, Norwich, United Kingdom.
26. Storsaeter J, Hallander HO, Gustafsson L, Olin P. 1998. Levels ofanti-pertussis antibodies related to protection after household exposure to Bordetella pertussis. Vaccine 16:1907-1916.
27. Taranger J, et al. 2000. Correlation between pertussis toxin IgG antibodies in postvaccination sera and subsequent protection against pertussis. J. Infect. Dis. 181:1010 -1013.
28. Teunis PF, et al. 2002. Kinetics of the IgG antibody response to pertussis toxin after infection with B. pertussis. Epidemiol. Infect. 129:479-489.
29. Watanabe M, Connelly B, Weiss AA. 2006. Characterization of serological responses to pertussis. Clin. Vaccine Immunol. 13:341-348.
30. Wendelboe AM, Van Rie A, Salmaso S, Englund JA. 2005. Duration of immunity against pertussis after natural infection or vaccination. Pediatr. Infect. Dis. J. 24:S58-S61.
31. WHO. 2010. Pertussis vaccines: WHO position paper. Wkly. Epidemiol. Rec. 85:385-400.